Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 43598-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Fosaprepitant Injection 150 mg per vial, a lyophilized powder for injection to be reconstituted with 5 mL of 0.9% Sodium Chloride. The single-dose vial is for intravenous use and dispensed by Dr. Reddy's Laboratories Inc. The label includes storage instructions, inactive ingredients, and a barcode, noting the product is made in India.*

FDA Label Image

Vial (Vial)

Label for Fosaprepitant For Injection, 150 mg per vial, lyophilized powder for intravenous use. The single-dose vial label includes storage instructions to refrigerate at 2°C to 8°C and distributor information for Dr. Reddy's Laboratories Inc. It also contains barcode and lot/expiration date fields, along with usage instructions and a note to discard unused portions.*

FDA Label Image

Structure (Structure)

Chemical structure of fosaprepitant depicted as a molecular diagram, showing detailed atomic connectivity and arrangement of the compound's chemical groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.